News Archive

IBBR researchers recently received $3.9 million from the National Institutes of Health (NIH) to develop a multi-specific, single agent antibody therapeutic against HIV-1 to block virus infection and to clear the reservoir of HIV-infected cells from the body.

The startup offering streaming health and fitness classes is expanding in corporate wellness. Former IKEA North America President Pernille Spiers-Lopez and Boulder Ventures' Josh Fidler joined the board.

Amazon’s move to Arlington will drive a demand for talent and help bring more venture capital into a region that has been slowly improving in that area.

This program will “offer operational guidance and financial support to Maryland startups founded by socially or economically disadvantaged entrepreneurs.”

How storytelling plays a part in the Baltimore startup community

RackTop Systems, a leading provider of high-performance Software-Defined Storage embedded with advanced security, encryption and compliance, and Network Runners, a top technology consulting services company that serves the commercial and federal government market spaces, today announced they will be

Baltimore biopharmaceutical company AsclepiX Therapeutics Inc. is developing therapies to target eye diseases.

MII portfolio company Asclepix Therapeutics raised over $5 million in new funding that will assist in development of new treatment for eye diseases that are leading causes of blindness in adults.

SERAXIS Inc., a rapidly growing regenerative medicine company today announced the publication of important trial considerations for SR-01, its pluripotent stem cell-derived islet therapy for insulin-dependent diabetes.

Longeveron LLC is a regenerative medicine company developing cellular solutions for aging-related diseases. The company is focused on the development of allogeneic (donor-derived) human mesenchymal stem cells (MSCs) that are harvested and grown at its manufacturing facility in Miami, Florida.

Viela Bio was featured this year at the TEDCO Entrepreneur Expo and Stem Cell Symposium as part of a special track on ‘Building Great Companies.’ Their panel discussion, titled ‘Corporate Spinouts: The Viela Bio Story,’ gave attendees a behind-the-scenes look at what went into the company’s launch

Aaron Ren is the head of business development and operations at startup Viela Bio, a MedImmune Inc. spinout. He spoke on a panel at TEDCO's Entrepreneur Expo along with some of the lawyers who worked on the spinout deal.

Oversubscribed round led by DataTribe, Bull City Ventures and TEDCO's Seed Fund

TEDCO Portfolio companies ClearMask and Plum Dragon